"Edge" across 2500 kilometers"
Release time:
2020-08-14
Crossing 2500 km "Edge"
■ Peak Health Wang Bingbing
In 2008 , I am about to graduate and face a major choice in my life-choosing a career. It was also at this time that the word "peak" entered my life. At that time, I was full of expectation and uneasiness. For a native northern girl, what will be waiting for me in this place 2500 kilometers away?
At the beginning of 2009 , I got on the south train alone and went through a journey of 48 hours to Jinhua, a southern city. I officially joined Jianfeng Pharmaceutical and became a QC in the Quality Control Department. I was 24 !
When I entered the laboratory, all my previous uneasiness disappeared, because this is a harmonious family with amiable teachers and vigorous friends. At the beginning, due to the language barrier, my colleagues tried their best to communicate in Mandarin in order to let me integrate into the group as soon as possible; the masters taught me various skills and experience hand in hand, which saved me a lot of detours and quickly completed it independently. Various inspection work. Jianfeng Pharmaceutical's production concept of "one bag, bottle, needle, one life" and the earnest teachings of the masters make me feel the responsibility on my shoulders as a quality manager.
During my time in the pharmaceutical industry, I also had an unexpected harvest, which was love. After Yin's general introduction, I got to know my husband and entered the palace of marriage in 2012 . I married directly from my "mother's family" and made the second major decision in my life. Since my husband belongs to the pharmaceutical development department, I have another "peak daughter-in-law" status.
In the 4 years and 4 months of Jianfeng Pharmaceutical, I have shed my youth and enriched myself through continuous efforts, laying the foundation for the future.
2013 7 May, I bid farewell to the "mentor" of Jianfeng Pharmaceutical and officially joined the preparation of Jianfeng Health. In the 5 years of peak health, I have challenged various positions, such as quality control, research and development, preparation of chain flagship stores, academic training, sales key account management, market management, etc. I have experienced every innovation and development of peak health. Recalling the past five years, there have been countless "firsts", the first time to open a store (chain flagship store preparation), the first time to switch (transferred to the marketing department), the first lecture (community training), the first time to face sales (sales of key account management)... It is these "firsts" that have built up the steps of my career. Of course, the most difficult one was that...
In 2015 , Jianfeng Health won the right to host the "Ninth Forum on Innovation and Development of Chinese Herbal Pieces and the Symposium on International Business Standards of Chinese Herbal Pieces. Originally, it was planned that the main venue would be located in Hangzhou and a professional conference team would be hired to take the exercise. However, due to various reasons, the main venue was finally set in Jinhua, and the task fell gloriously to my then partner Xu Yuting and me. In two months, we have to arrange the agenda of the meeting, sponsor, invite speeches and guests to attend the meeting, and for a high-level seminar like this, the guests must also be well-known experts and elites in the industry. For the newcomers, it is almost impossible to complete the task with no experience and resources.
The most difficult thing is to invite guests to the conference. Because they have no resources on hand, they can only go to the websites of relevant enterprises to inquire about the contact information. However, when they call, they are often regarded as swindlers and do not want to pay attention to them. Through the introduction of teachers and classmates and the recommendation of peers, we finally won the trust of some people in the industry, the popularity of Jianfeng Health has also increased, and many enterprises have taken the initiative to come to the door to sign up for the meeting. When the meeting was finally held, Ren Daquan, former deputy director of the State Food and Drug Administration, 15 experts and professors in the industry, and more than 100 well-known entrepreneurs in the field of Chinese herbal pieces came to attend, which not only achieved a complete success, but also was highly valued by the Jinhua Municipal Government. Therefore, I was promoted to the head of the marketing department, which really started my marketing career.
In recent years, the marketing department has carried out many reforms according to the strategic adjustment of peak health, trying chain stores, e-commerce, sales, new micro-commerce and other modes, and the publicity method has also evolved from traditional paper media advertising to outdoor, car body, network and other emerging media. 2017 , we also tried to buy TV shopping, opened Jinhua terminal market, and launched large-scale push activities such as "Jianfeng Walking, Bone Tailai Refueling" and "Jianfeng Bone Tai Free Clinic Community Tour. 2018 , in order to further promote the new micro-business model, the marketing department also organized the development of 6 functional foods suitable for the promotion of new micro-business. With the development of Jianfeng Group, Jianfeng Health is also making unremitting efforts and constantly trying to move forward courageously. I am also constantly looking for myself in it.
2018 is the 73rd anniversary of peak venture 60#. I am honored to witness this moment and am grateful to be able to walk through the best 10 years of my life hand in hand with peak. I believe that with the joint efforts of all the peak staff, the peak career can flourish and create greater brilliance!
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31